Literature DB >> 28959286

Prokaryotic Expression, Purification, and Polyclonal Antibody Production of a Truncated Recombinant Rabies Virus L Protein.

Jinyang Zhang1, Zian Jin1, Tao Sun1, Yan Jiang1, Qinqin Han1, Yuzhu Song1, Qiang Chen1, Xueshan Xia1.   

Abstract

BACKGROUND: Rabies virus (RABV) is a deadly neurotropic virus that causes the disease of rabies in humans and animals. L protein is one of the large structural protein of rabies virus, which displays multiple enzymatic activities, and is required for viral transcription and replication.
OBJECTIVES: A truncated L protein of Rabies virus is being cloned, expressed and purified to produce relevant polyclonal antibody.
MATERIALS AND METHODS: The gene fragment of L protein of RABV was subcloned into prokaryotic expression vector pET- 28a and transformed into E. coli Rosetta DE3 host strain. The recombinant L protein of RABV was expressed and characterized by SDS-PAGE and western blot analysis using anti-his tag antibody. Mice were immunized with the purified recombinant L protein, the reaction of the anti-serum was checked by immunofluorescence and dot-blot, respectively.
RESULTS: The results of PCR and sequencing confirmed that the fragment of L gene of RABV was successfully cloned into the expression vector. The expression of recombinant L protein fragment induced by IPTG was confirmed by the band of 43 kDa in SDS-PAGE and western blot. The antiserum of purified L protein immunized mice was reacted with RABV infected N2a cells and suckling mouse brain tissue lysates.
CONCLUSIONS: Our data showed that the recombinant L protein produced by pET-28a vector was very successful, and the purified L protein could efficiently induce the antibody response in mice. The antiserum could recognize the virus in RABV infected cells and tissue very well.

Entities:  

Keywords:  L protein; Polyclonal antibody; Prokaryotic expression; Rabies virus

Year:  2015        PMID: 28959286      PMCID: PMC5435001          DOI: 10.15171/ijb.1022

Source DB:  PubMed          Journal:  Iran J Biotechnol        ISSN: 1728-3043            Impact factor:   1.671


  34 in total

1.  Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness.

Authors:  Satoko Yamaoka; Naoto Ito; Seii Ohka; Shohei Kaneda; Hiroko Nakamura; Takahiro Agari; Tatsunori Masatani; Keisuke Nakagawa; Kazuma Okada; Kota Okadera; Hiromichi Mitake; Teruo Fujii; Makoto Sugiyama
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Structure of the dimerization domain of the rabies virus phosphoprotein.

Authors:  Ivan Ivanov; Thibaut Crépin; Marc Jamin; Rob W H Ruigrok
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

3.  Amino acid substitution at position 95 in rabies virus matrix protein affects viral pathogenicity.

Authors:  Naoto Ito; Tetsuo Mita; Kenta Shimizu; Yuki Ito; Tatsunori Masatani; Keisuke Nakagawa; Satoko Yamaoka; Masako Abe; Kota Okadera; Nobuyuki Minamoto; Makoto Sugiyama
Journal:  J Vet Med Sci       Date:  2011-06-07       Impact factor: 1.267

4.  A novel nuclear trafficking module regulates the nucleocytoplasmic localization of the rabies virus interferon antagonist, P protein.

Authors:  Sibil Oksayan; Linda Wiltzer; Caitlin L Rowe; Danielle Blondel; David A Jans; Gregory W Moseley
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

5.  Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.

Authors:  Naoto Ito; Gregory W Moseley; Danielle Blondel; Kenta Shimizu; Caitlin L Rowe; Yuki Ito; Tatsunori Masatani; Keisuke Nakagawa; David A Jans; Makoto Sugiyama
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

6.  Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model.

Authors:  Qunfeng Wu; Fulai Yu; Jinfang Xu; Yang Li; Huanchun Chen; Shaobo Xiao; Zhen F Fu; Liurong Fang
Journal:  Vet Microbiol       Date:  2014-04-03       Impact factor: 3.293

7.  Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology.

Authors:  Murali Varma; Meleri Morgan; Bharat Jasani; Pheroze Tamboli; Mahul B Amin
Journal:  Am J Clin Pathol       Date:  2002-08       Impact factor: 2.493

8.  Rabies virus M protein expressed in Escherichia coli and its regulatory role in virion-associated transcriptase activity.

Authors:  Y Ito; A Nishizono; K Mannen; K Hiramatsu; K Mifune
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Importance of rabies virus nucleoprotein in viral evasion of interferon response in the brain.

Authors:  Tatsunori Masatani; Naoto Ito; Yuki Ito; Keisuke Nakagawa; Masako Abe; Satoko Yamaoka; Kota Okadera; Makoto Sugiyama
Journal:  Microbiol Immunol       Date:  2013-07       Impact factor: 1.955

10.  Enhanced expression of rabies virus surface G-protein in Escherichia coli using SUMO fusion.

Authors:  Ankit Singh; Dinesh Yadav; Krishan Mohan Rai; Meenal Srivastava; Praveen C Verma; Pradhyumna K Singh; Rakesh Tuli
Journal:  Protein J       Date:  2012-01       Impact factor: 2.371

View more
  3 in total

1.  MitoKATP channels promote the proliferation of hypoxic human pulmonary artery smooth muscle cells via the ROS/HIF/miR-210/ISCU signaling pathway.

Authors:  Hongling Hu; Yu Ding; Yang Wang; Shuang Geng; Jue Liu; Jinrong He; Yang Lu; Xueying Li; Mingli Yuan; Shan Zhu; Su Zhao
Journal:  Exp Ther Med       Date:  2017-10-17       Impact factor: 2.447

2.  Production and Partial Purification of the Grapevine Fanleaf Virus Coat Protein 42 Polyclonal Antibody Against Inclusion Body Expressed in Escherichia coli.

Authors:  Naeimeh Shibaei; Jafar Majidi; Nemat Sokhandan Bashir; Aliasghar Karkhaneh; Khadijeh Razavi
Journal:  Iran J Biotechnol       Date:  2018-12-12       Impact factor: 1.671

3.  Development of Monoclonal Antibodies for Detection of Conserved and Variable Epitopes of Large Protein of Rabies Virus.

Authors:  Wen Zhao; Jingyin Su; Naiyu Zhao; Jie Liu; Shuo Su
Journal:  Viruses       Date:  2021-01-31       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.